Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_assertion description "[In inflammatory bowel disease, increased production of prostaglandins by cyclooxygenase-2 (COX-2) contributes to bowel dysfunction, inflammatory edema, and hyperemia suggesting that inhibitors of COX-2 may have beneficial effect in gut inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_assertion evidence source_evidence_curated NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_assertion SIO_000772 11820457 NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_assertion wasDerivedFrom ctd_human-20130708 NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_assertion wasGeneratedBy ECO_0000218 NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP27706.RAh9BLDU_jw2HsUYqFp8IRJzF3zlTc-4BQyKubNX5vaH0130_provenance.